Quote & Headlines
5d 1m 3m 1y 5y 10y
To learn more about Seeking Alpha PRO, click here.
There are no Transcripts on RBXZF.
There are no News articles on RBXZF.
RBXZF vs. ETF Alternatives
Thursday, Aug 22012, 11:13 AMGilead Sciences (GILD +8.3%) says it plans to partner with Mylan (MYL -1.5%), Ranbaxy Laboratories (RBXZF.PK) and Strides Arcolab to promote access to generic versions of Gilead's HIV medicine containing Emtricitabine in developing countries. The drug is marketed by GILD under the brand names Emtriva and Truvada. WHO guidelines recommend the drug as preferred components of first and second line HIV therapy. |Thursday, Aug 22012, 11:13 AM| Comment!